The DOI matches its Crossref record; 154 of the 158 references it cites were found in a registry or an index.
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
Open accessAbstract
Background: Diabetes mellitus and cancer are commonly coexisting illnesses, and the global incidence and prevalence of both are rising. Cancer patients with diabetes face unique challenges. This review highlights the relationship between diabetes and cancer and various aspects of the management of diabetes in cancer patients. Methods: A literature search using keywords in PubMed was performed. Studies that were published in English prior to July 2021 were assessed and an overview of epidemiology, cancer risk, outcomes, treatment-related hyperglycemia and management of diabetes in cancer patients is provided. Results: Overall, 8–18% of cancer patients have diabetes as a comorbid medical condition. Diabetes is a risk factor for certain solid malignancies, such as pancreatic, liver, colon, breast, and endometrial cancer. Several novel targeted compounds and immunotherapies can cause hyperglycemia. Nevertheless, most patients undergoing cancer therapy can be managed with an appropriate glucose lowering agent without the need for discontinuation of cancer treatment. Evidence suggests that cancer patients with diabetes have higher cancer-related mortality; therefore, a multidisciplinary approach is important in the management of patients with diabetes and cancer for a better outcome. Conclusions: Future studies are required to better understand the underlying mechanism between the risk of cancer and diabetes. Furthermore, high-quality prospective studies evaluating management of diabetes in cancer patients using innovative tools are needed. A patient-centered approach is important in cancer patients with diabetes to avoid adverse outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Likewise, interindividual variability in baseline management, comorbidities, insulin sensitivity, and mode of insulin delivery (MDI, AID, or HCL/AHCL) contribute to the wide range of adjustments reported.”
From A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies (2026) · cites this paper as [62]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Richness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
André, F., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H. S., Iwata, H., Conte, P., Mayer, I. A., Kaufman, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813904 · Cited by 2,622
Rinke, A., Müller, H., Schade‐Brittinger, C., Klose, K., Barth, P. J., Wied, M., Mayer, C., Aminossadati, B., Pape, U., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,507
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Cited by
Sorted by citations
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
Pati, S., Irfan, W., Jameel, A., Ahmed, S., & Shahid, R. K. (2023) · Cancers · doi:10.3390/cancers15020485 · Cited by 677
Self-citationAnnual report to the nation on the status of cancer, part 1: National cancer statistics
Cronin, K. A., Scott, S., Firth, A. U., Sung, H., Henley, S. J., Sherman, R., Siegel, R. L., Anderson, R. N., Kohler, B., Benard, V. B., et al. (2022) · Cancer · doi:10.1002/cncr.34479 · Cited by 577
New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis
Harborg, S., Kjærgaard, K. A., Thomsen, R. W., Borgquist, S., Cronin-Fenton, D. P., & Hjorth, C. F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad450 · Cited by 113
Cortellini, A., D’Alessio, A., Cleary, S., Buti, S., Bersanelli, M., Bordi, P., Tonini, G., Vincenzi, B., Tucci, M., Russo, A., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3116 · Cited by 78
The obesity pandemic and its impact on non-communicable disease burden
Hildebrand, S., & Pfeifer, A. (2025) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-025-03066-8 · Cited by 71
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer
Ibrahim, S. S., Ibrahim, R. S., Arabi, B., Brockmueller, A., Shakibaei, M., & Büsselberg, D. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10192-9 · Cited by 56
Asao, T., Tobias, G. C., Lucotti, S., Jones, D. R., Matei, I. R., & Lyden, D. C. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.37 · Cited by 51
Lipid droplets provide metabolic flexibility for cancer progression
Safi, R., Menéndez, P. R., & Pol, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14820 · Cited by 50
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 53
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Dhas, Y., Biswas, N., Divyalakshmi, M. R., Jones, L., & Ashili, S. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00204-z · Cited by 45
Asiri, A., Qarni, A. A. A., & Bakillah, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192132 · Cited by 37
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
Perelman, M. G., Brzezinski, R. Y., Waissengrin, B., Leshem, Y., Bainhoren, O., Rubinstein, T. A., Perelman, M., Rozenbaum, Z., Havakuk, O., Topilsky, Y., et al. (2024) · Cardio-Oncology · doi:10.1186/s40959-023-00199-6 · Cited by 32
Silvestris, N., Franchina, T., Gallo, M., Argentiero, A., Avogaro, A., Cirino, G., Colao, A. A. L., Danesi, R., Cianni, G. D., D’Oronzo, S., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.102062 · Cited by 32
Peng, Y., Wang, P., Gong, J., Liu, F., Qiao, Y., Si, C., Wang, X., Zhou, H., & Song, F. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155586 · Cited by 26
Diabetes and Cancer: A Twisted Bond
Stan, M. C., & Paul, D. (2024) · Oncology Reviews · doi:10.3389/or.2024.1354549 · Cited by 30
Insulin resistance and cancer: molecular links and clinical perspectives
Caturano, A., Erul, E., Nilo, R., Nilo, D., Russo, V., Rinaldi, L., Acierno, C., Gemelli, M. T., Ricotta, R., Sasso, F. C., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05245-8 · Cited by 27
Zhang, Y.-C., Lyu, Z., Ma, B., Li, L., Wang, W., Sheng, C., Dai, H., Huang, Y., Song, F.-F., Song, F., et al. (2022) · Hepatology International · doi:10.1007/s12072-022-10362-3 · Cited by 26
Wang, L. F., Yin, Y., Glampson, B., Peach, R. L., Barahona, M., Delaney, B. C., & Mayer, E. K. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105442 · Cited by 31
Tuning insulin receptor signaling using de novo-designed agonists
Wang, X., Cardoso, S., Cai, K., Venkatesh, P., Hung, A., Ng, M., Hall, C., Coventry, B., Lee, D. S., Chowhan, R., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.09.020 · Cited by 24
High Glucose Increases DNA Damage and Elevates the Expression of Multiple DDR Genes
Rahmoon, M. A., Elghaish, R. A., Ibrahim, A. A., Alaswad, Z., Gad, M. Z., El‐Khamisy, S. F., & Elserafy, M. (2023) · Genes · doi:10.3390/genes14010144 · Cited by 25
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 26
Diabetes and skin cancers: Risk factors, molecular mechanisms and impact on prognosis
Dobrică, E.-C., Banciu, L. M., Kipkorir, V., Tabari, M. A. K., Cox, M. J., Kutikuppala, L. V. S., & Găman, M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11214 · Cited by 23
Sharma, N., Khatib, M. N., Balaraman, A. K., Roopashree, R., Kaur, M., Srivastava, M., Barwal, A., Prasad, G. V. S., Rajput, P., Syed, R., et al. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04266-4 · Cited by 21
Saha, A., Moitra, S., & Sanyal, T. (2022) · doi:10.52756/bhietm.2022.e01.001 · Cited by 21
Gheorghe, D. N., Camen, A., Popescu, D. M., Şincar, C. D., Pitru, A. R., Ionele, C. M., Nicolae, F. M., Danilescu, C. M., Roman, A., & Florescu, C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030341 · Cited by 20
Al‐Taie, A., & Sheta, N. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.10.016 · Cited by 19
Ramos, C. C., Pires, J., González, E., Garcia‐Vallicrosa, C., Reis, C. A., Falcón‐Pérez, J. M., & Freitas, D. P. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2024.36 · Cited by 19
Rashid, R. S. M., Temurlu, S., Abourajab, A., Karsili, P., Dinleyici, M., Al-Khateeb, B., & Icil, H. (2023) · Pharmaceuticals · doi:10.3390/ph16040555 · Cited by 16
Narayanan, M. (2026) · Discover Public Health · doi:10.1186/s12982-026-01431-1 · Cited by 18
Wang, J., Tang, Y., Liu, Y., Cai, W., & Xu, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.974938 · Cited by 15
Elsaman, T., Muddathir, A. M., Mohieldin, E. A. M., Batubara, I., Rahminiwati, M., Yamauchi, K., Mohamed, M. A., Asoka, S. F., Büsselberg, D., Habtemariam, S., et al. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00586-5 · Cited by 15
O‑GlcNAcylation mediates endometrial cancer progression by regulating the Hippo‑YAP pathway
Zhai, L., Yang, X., Dong, J., Qian, L., Gao, Y., Lv, Y., Chen, L., Chen, B., & Zhou, F. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5538 · Cited by 14
Chen, N., Zhou, J., Wang, K., Li, X., & Li, Z. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003066 · Cited by 13
Deligiorgi, M. V., & Trafalis, D. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087630 · Cited by 13
Liu, M., Xia, Q., Wu, X., Jin, S., Xie, Y., Yan, R., Jin, Y., & Wang, Z. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00184 · Cited by 13
Khan, I., Kamal, A., & Akhtar, S. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01387-6 · Cited by 12
Nutrition and Diet Patterns as Key Modulators of Metabolic Reprogramming in Melanoma Immunotherapy
Grafanaki, K., Maniatis, A., Anastogianni, A., Bania, A., Pasmatzi, E., & Stathopoulos, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124193 · Cited by 12
A review on application of polymers-based optical chemosensors in glucose detection
Mohammadzadeh, F., Golshan, M., Haddadi‐Asl, V., & Salami‐Kalajahi, M. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.114008 · Cited by 10
Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin
Ma, X., Sun, C., Ding, X., Zhang, Y., Deng, T., Wang, Y., Yang, H., Ding, R., Li, H., Wang, D., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1482050 · Cited by 9
Type 2 Diabetes Mellitus and bladder cancer: A narrative review on associated signaling pathways
Agostini, L. D. C., & da Silva, G. N. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101381 · Cited by 9
Santo, V., Brunetti, L., Pecci, F., Peroni, M., Barnini, G., Paoloni, F., Buti, S., Tiseo, M., Ricciuti, B., Pinato, D. J., et al. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01718-7 · Cited by 10
Terao, N. (2022) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2022.100172 · Cited by 9
Chang, T.-Y., Lan, K., Wu, C.-H., Sheu, M., Yang, R., & Liu, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90817 · Cited by 9
Sensitivity of the Neuroendocrine Stress Axis in Metabolic Diseases
Cozma, D., Siatra, P., Bornstein, S. R., & Steenblock, C. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2201-6641 · Cited by 9
Aloizou, A., Palaiodimou, L., Aloizou, D., Dardiotis, E., Gold, R., Tsivgoulis, G. K., & Krogias, C. (2023) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864231180717 · Cited by 8
Vinothkanna, A., Shi‐Liang, X., Rajan, D. K., Prathiviraj, R., Sekar, S., Zhang, S., Wang, B., Liu, Z., & Jia, A. (2024) · Food Frontiers · doi:10.1002/fft2.406 · Cited by 8
Chronic Stress Related to Cancer Incidence, including the Role of Metabolic Syndrome Components
Pham, A. T., van Dijk, B. A. C., van der Valk, E. S., van der Vegt, B., van Rossum, E. F. C., & de Bock, G. H. (2024) · Cancers · doi:10.3390/cancers16112044 · Cited by 9
Durrani, I. A., John, P., Bhatti, A., & Khan, J. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36650 · Cited by 9
Obesity as a Systems‐Level Driver of Cancer: Mechanisms and Nutritional Reprogramming
Munteanu, C., & Dhanasekaran, D. N. (2025) · Obesity Reviews · doi:10.1111/obr.70075 · Cited by 8
Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention
Azani, A., Avval, N. A., Meigoli, M. S. S., Imankhan, M., Asgari, P., Ebrahimisaraj, G., Morovatshoar, R., Hosseini, A. M., Mirzohreh, S., Nouri, M., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-03264-x · Cited by 8
Gariazzo, E., Colamartini, F., Ubaldi, M., Santo, V., Brunetti, L., Tomarelli, C., Ognissanti, D., Nassar, J., Costabile, S., Romano, L., et al. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s567238 · Cited by 7
Wadaan, M. A., Baabbad, A., & Farooq, M. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117764 · Cited by 7
Mellor, R., Girgis, C. M., Rodrigues, A. C., Chen, C., Cuan, S., Gambhir, P., Perera, L., Veness, M., Sundaresan, P., & Gao, B. (2024) · Current Oncology · doi:10.3390/curroncol31020061 · Cited by 7
Bhargavan, R. V., Philip, F. A., Krishna, K. M. J., Augustine, P., & Thomas, S. (2024) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-024-01995-x · Cited by 7
Reverse cardio-oncology: A budding concept
Satpathy, C., Mishra, T. K., Singh, S., & Jha, A. K. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.09.004 · Cited by 7
Yang, R., Wang, L., & Shui, C. (2023) · International Wound Journal · doi:10.1111/iwj.14420 · Cited by 7
Paris, J., Legris, P., Devaux, M., Bost, S., Gueneau, P., Rossi, C., Manfrédi, S., Bouillet, B., Petit, J., Pistre, P., et al. (2023) · Cancers · doi:10.3390/cancers15184544 · Cited by 7
A Review on In-vivo and In-vitro Models of Obesity and Obesity-Associated Co-Morbidities
Nath, D., Barbhuiya, P. A., Sen, S., & Pathak, M. P. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303312932240801073903 · Cited by 6
Yu, X., Fu, B., Sun, T., & Sun, X. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1449881 · Cited by 6
Loktionova, M. V., Mohammadian, M., Choopani, R., Kheiri, S., & Mohammadian-Hafshejani, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314565 · Cited by 6
RetractedDing, L., Qian, J., Dai, R., Zhang, H., Miao, J., Wang, J., Yu, M., Tan, X. W., & Li, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-13470-z · Cited by 6
Tan, Y., Kang, J., Li, H., Zhong, A., Liu, Y., Zhang, Z., Huang, R., Cheng, X. M., & Peng, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149810 · Cited by 6
Sucholeiki, R. L., Propst, C. L., Hong, D. S., & George, G. C. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102725 · Cited by 6
Cardiometabolic perturbations arising from treatment with novel anticancer therapies
Bennetts, J. D., Sverdlov, A. L., & Ngo, D. T. M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.10.008 · Cited by 5
Chen, Z., Cai, L., Qin, Q., Li, X., Lu, S., Sun, L., Zhang, Y., Qi, L., & Zhou, T. (2024) · Journal of Physical Activity and Health · doi:10.1123/jpah.2023-0576 · Cited by 5
Perioperative Management of Patients with Diabetes and Cancer: Challenges and Opportunities
Shouman, M. G., Brabant, M., Rehman, N., Ahmed, S., & Shahid, R. (2024) · Cancers · doi:10.3390/cancers16162821 · Cited by 5
Self-citationEffects of Diabetes on Inflammatory Status and Prognosis in Cancer Patients
Liu, X., Zheng, K., Ji, W., Zhang, W., Li, Y., Liu, M., Cui, J., & Li, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.792577 · Cited by 5
Peng, Y., Liu, F., Wang, P., Qiao, Y., Si, C., Wang, X., Gong, J., Zhou, H., Song, F., & Song, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1277935 · Cited by 5
Liu, Y., Liu, H., Liu, J., Liu, W., Yang, Y., & Liu, Y. (2024) · Nutrition and Cancer · doi:10.1080/01635581.2024.2380521 · Cited by 5
Chomphoo, S., Kunprom, W., Thithuan, K., Sorin, S., Khawkhiaw, K., Kamkaew, A., Phoomak, C., Chiu, C., & Saengboonmee, C. (2023) · In Vivo · doi:10.21873/invivo.13129 · Cited by 6
Abdullah, S., & Chatterjee, P. K. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100772 · Cited by 4
Abdullah, K. M., Sharma, G., Anjum, B., Alam, M. F., Yadav, S., Singh, Y., Sinha, R. A., Venkatesh, V., Siddiqui, J. A., & Chakravarti, B. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101458 · Cited by 4
Self-citationCho, J., Higgason, N. M., Rothman, J., Safford, M. M., & Pinheiro, L. C. (2024) · Journal of Cancer Education · doi:10.1007/s13187-024-02425-w · Cited by 5
Cancer Prevention: Principles and Approaches
Kuczynski, G., & Gotay, C. C. (2024) · Global perspectives on health geography · doi:10.1007/978-3-031-66413-7_2 · Cited by 4
Impact of poorly controlled type II diabetes mellitus on chemoresistance in colorectal cancer
Gaur, A., Maity, R., Dhali, A., & Biswas, J. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i11.104065 · Cited by 4
Racial disparities in diabetes prevalence among cancer patients
Ashing, K. T., Song, G., Jones, V., Brenner, C., & Samoa, R. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1099566 · Cited by 4
Katz, A., Shulkin, A., Housni, A., Roy‐Fleming, A., Rabasa‐Lhoret, R., Yale, J., Tsoukas, M. A., Peters, T. M., & Brazeau, A. (2026) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70465 · Cited by 3
Soliman, A. R., Ahmed, R. M., Meligi, A. A. H. E., Abo-Zeid, A. G., Amer, M. A., Atef, A., Yousry, A., Saleh, A. A., Fahmy, E. M., Makar, W., et al. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00513-x · Cited by 3
Wang, J., Xiang, P., Zhao, E., Liu, L., Liu, Y., Liang, L.-J., Cui, Y., & Fang, B. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03982-0 · Cited by 3
Saad, M., Ali, D., Khan, T. M., Batool, R. M., Arshad, M. S., Collins, P. L., & Ahmed, R. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70092 · Cited by 3
Jiménez-Ortega, A. D., Galeana-Pizaña, J. M., Bello, G. M. C., & Núñez, J. M. (2025) · Health & Place · doi:10.1016/j.healthplace.2025.103555 · Cited by 3
Elian, V., Popovici, V., Nicolescu, M. I., Nicolescu, A. M., Aurelian, S. M., & Ozon, E. A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47110929 · Cited by 3
Lucà, F., & Parrini, I. (2025) · Discover Oncology · doi:10.1007/s12672-025-04046-1 · Cited by 3
Bhatti, G. K., Ahmed, I., Sehrawat, A., Sharma, P. K., Kandimalla, R., Bhatti, J. S., & Bhatti, J. S. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101464 · Cited by 4
Gallo, M., Lasagna, A., Renzelli, V., Morviducci, L., Cortellini, A., Monami, M., Marino, G., Gori, S., Verzè, M., Ragni, A., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02586-5 · Cited by 3
Jeong, S., Poudyal, S., Klagges, S., Kuhnt, T., Papsdorf, K., Hambsch, P. K., Wach, J., Güresir, E., Nägler, F., Rühle, A., et al. (2023) · Cancers · doi:10.3390/cancers15194845 · Cited by 3
Attia, S. M., Ahmad, S. F., Nadeem, A., Attia, M. S. M., Ansari, M. A., Ashour, A. E., Albekairi, N. A., Al‐Hamamah, M. A., Alshamrani, A. A., & Bakheet, S. A. (2023) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2023.503707 · Cited by 3
Poor Glycemic Control Affecting Screening of Prostate Carcinoma
Bharti, A., Shekhar, R., Prakash, P., Kumari, S., & Kumar, S. (2024) · Cureus · doi:10.7759/cureus.58680 · Cited by 3
Koo, H. Y., Han, K., Cho, M. H., Jung, W., Jung, J., Cho, I. Y., & Shin, D. W. (2024) · Cancer Research and Treatment · doi:10.4143/crt.2024.586 · Cited by 3
Shahid, R. K., Haider, Q., Yadav, S., Le, D., & Ahmed, S. (2024) · Clinical Medicine · doi:10.1016/j.clinme.2024.100262 · Cited by 3
Self-citationPalliative management of type 2 diabetes mellitus in patients with advanced cancer
Weerasinghe, A., Good, P. D., Stokes, C., Chen, J., & Gurgenci, T. (2025) · Australian Journal of General Practice · doi:10.31128/ajgp-01-25-7522 · Cited by 3
Drug Repositioning for Ovarian Cancer Treatment: An Update
Cavalluzzi, M. M., Viale, M., Rotondo, N. P., Ferraro, V., & Lentini, G. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206282904240122063914 · Cited by 5
Jung, M., Jung, M.-K., Kim, E.-S., Youn, J., Lee, E. Y., Kang, D., Kyoung, D., Chung, W., Jung, H. O., Ihm, S., et al. (2025) · Cancers · doi:10.3390/cancers17071117 · Cited by 2
Multi-omics insights into biomarkers of breast cancer associated diabetes: a computational approach
Loganathan, T., & Doss, C. G. P. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1572500 · Cited by 2
Ziyanok, S. (2025) · Doğu Karadeniz Sağlık Bilimleri Dergisi · doi:10.59312/ebshealth.1765591 · Cited by 2
Obesity and GEP-NEN: what’s new?
Boschetti, M., Hasballa, I., Patelli, I., Piras, G., & Albertelli, M. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.12.006 · Cited by 2
Marine nutraceuticals and their role in modulating diabetes-induced carcinogenesis
Limijadi, E. K. S., Nishani, F., Daliu, P., Qorri, E., Hadinata, E., Santini, A., & Nurkolis, F. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02113-3 · Cited by 2
The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology
Boroomand, F., Karimi, M. A., Karimzadeh‐Soureshjani, E., Kiani-Shamsabadi, D., Farhang, F., Mardani, H., & Jafari, A. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01147-8 · Cited by 2
Rivera, R. G., Regidor, P. J. S., Ruamero, E. C., Santos, C. D. R. D., Gomez, C. B., Allanigue, E. J. V., & Salinas, M. V. (2023) · Acta Medica Philippina · doi:10.47895/amp.vi0.7351 · Cited by 2
Frost, S., Ziarati, P., Moen, R., Kysh, L., Johnson, R., Pearce, S. M., Daneshmand, S., Siegmund, K. D., & Cortessis, V. K. (2024) · Journal of Urologic Oncology · doi:10.22465/juo.244600020001 · Cited by 2
Metadata
- Authors
- Shahid, R. K., Ahmed, S., Le, D., & Yadav, S.
- Affiliations
- University of Saskatchewan (CA)
- Corresponding author
- Ahmed, Shahid
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-11-16
- Volume
- 13
- Issue
- 22
- Pages
- 5735
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8616213
- OpenAlex
- W3213879794
- Cited by
- 187
- References
- 158
- Citations by year
- 2026: 44 · 2025: 54 · 2024: 41 · 2023: 34 · 2022: 13 · 2021: 1
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, cancer, comorbidities, cancer risk, glucose-lowering agents, cancer mortality, immune-related adverse events, targeted therapy, multidisciplinary management, pancreatic cancer, liver cancer, breast cancer, endometrial cancer, colon cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
